154 related articles for article (PubMed ID: 37906285)
1. Human Placenta and Evolving Insights into Pathological Changes of Preeclampsia: A Comprehensive Review of the Last Decade.
Chiorean DM; Cobankent Aytekin E; Mitranovici MI; Turdean SG; Moharer MS; Cotoi OS; Toru HS
Fetal Pediatr Pathol; 2024; 43(1):33-46. PubMed ID: 37906285
[TBL] [Abstract][Full Text] [Related]
2. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array.
Yagel S; Cohen SM; Goldman-Wohl D
Am J Obstet Gynecol; 2022 Feb; 226(2S):S963-S972. PubMed ID: 33712272
[TBL] [Abstract][Full Text] [Related]
3. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
Ren Z; Cui N; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
[TBL] [Abstract][Full Text] [Related]
4. Expert review: preeclampsia Type I and Type II.
Yagel S; Cohen SM; Admati I; Skarbianskis N; Solt I; Zeisel A; Beharier O; Goldman-Wohl D
Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101203. PubMed ID: 37871693
[TBL] [Abstract][Full Text] [Related]
5. Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction.
Lorenz-Meyer LA; Frank L; Sroka D; Busjahn A; Henrich W; Verlohren S
Pregnancy Hypertens; 2022 Jun; 28():149-155. PubMed ID: 35453103
[TBL] [Abstract][Full Text] [Related]
6. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta.
Jena MK; Sharma NR; Petitt M; Maulik D; Nayak NR
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599856
[TBL] [Abstract][Full Text] [Related]
8. Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies.
Hoeller A; Ehrlich L; Golic M; Herse F; Perschel FH; Siwetz M; Henrich W; Dechend R; Huppertz B; Verlohren S
Hypertens Pregnancy; 2017 May; 36(2):151-160. PubMed ID: 28609172
[TBL] [Abstract][Full Text] [Related]
9. Reduced angiogenic factor expression in intrauterine fetal growth restriction using semiquantitative immunohistochemistry and digital image analysis.
Alahakoon TI; Zhang W; Arbuckle S; Zhang K; Lee V
J Obstet Gynaecol Res; 2018 May; 44(5):861-872. PubMed ID: 29392826
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation profiles of genes associated with angiogenesis in the samples of placenta in pregnancies complicated by intrauterine growth restriction.
Selcen Cebe F; Nur Tola E; Aslan Koşar P; Oral B
J Matern Fetal Neonatal Med; 2021 Sep; 34(17):2854-2862. PubMed ID: 31581866
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.
Stepan H; Galindo A; Hund M; Schlembach D; Sillman J; Surbek D; Vatish M
Ultrasound Obstet Gynecol; 2023 Feb; 61(2):168-180. PubMed ID: 35816445
[TBL] [Abstract][Full Text] [Related]
12. Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat.
Barrientos G; Pussetto M; Rose M; Staff AC; Blois SM; Toblli JE
Mol Hum Reprod; 2017 Jul; 23(7):509-519. PubMed ID: 28402512
[TBL] [Abstract][Full Text] [Related]
13. Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction.
Dymara-Konopka W; Laskowska M; Grywalska E; Hymos A; Błażewicz A; Leszczyńska-Gorzelak B
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674486
[TBL] [Abstract][Full Text] [Related]
14. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
Gu Y; Lewis DF; Wang Y
J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
[TBL] [Abstract][Full Text] [Related]
15. Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia.
Ehrlich L; Hoeller A; Golic M; Herse F; Perschel FH; Henrich W; Dechend R; Huppertz B; Verlohren S
Hypertens Pregnancy; 2017 May; 36(2):175-185. PubMed ID: 28494189
[TBL] [Abstract][Full Text] [Related]
16. Intrauterine growth restriction, soluble fms-like tyrosine kinase-1 to placental growth factor ratio increase and preeclampsia.
Boulanger H; Drouin D; Largilliere C; Lefèvre G
J Gynecol Obstet Hum Reprod; 2019 Oct; 48(8):695-697. PubMed ID: 31085278
[TBL] [Abstract][Full Text] [Related]
17. The Use of Soluble FMS-like Tyrosine Kinase 1/Placental Growth Factor Ratio in the Clinical Management of Pre-eclampsia.
Govender N; Moodley J; Naicker T
Afr J Reprod Health; 2018 Dec; 22(4):135-143. PubMed ID: 30632730
[TBL] [Abstract][Full Text] [Related]
18. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
19. Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms.
Tan L; Chen Z; Sun F; Zhou Z; Zhang B; Wang B; Chen J; Li M; Xiao T; Neuman RI; Niu J; Verdonk K; Lu X; Zhang JV; Danser AHJ; Yang Q; Fan X
Clin Sci (Lond); 2022 Feb; 136(4):257-272. PubMed ID: 35103285
[TBL] [Abstract][Full Text] [Related]
20. Urinary placental growth factor in preeclampsia and fetal growth restriction: An alternative to circulating biomarkers?
Zhang K; Zen M; Popovic NL; Lee VW; Alahakoon TI
J Obstet Gynaecol Res; 2019 Sep; 45(9):1828-1836. PubMed ID: 31257726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
